https://www.selleckchem.com/pe....ptide/dulaglutide.ht
0001. Although relative benefits were similar, absolute risk reduction from atorvastatin 80mg was lowest when both scores were
<median (1.3%, group 1) and highest when both were>
median (7.2%, group 4), NNT 78 vs. 14 (p-interaction 0.0001). Measures of residual risk as well LDL-C identify patients who remain at high risk despite statins with the combination identifying those who derive the greatest benefits from even modest additional LDL-C lowering. Attention to residual risk as well as LDL-C may further help to optimize gui